Sonographic findings in coronavirus disease-19 associated liver damage.
Jakob SpogisFlorian HagenWolfgang M ThaissTatjana HoffmannNisar MalekKonstantin NikolaouChristoph P BergStephan SingerHans BösmüllerFlorian KrethSascha KaufmannPublished in: PloS one (2021)
For most hospitalized COVID-19 patients, elevated liver enzymes cause little concern as they are only mild to moderate. However, in severely ill patients bedside sonography is a powerful tool to reveal different patterns of vascular, cholestatic or inflammatory complications in the liver, which are associated with high mortality. In addition, macrophage activation as histopathologic correlate for a hyperinflammatory syndrome seems to be a frequent complication in COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- oxidative stress
- newly diagnosed
- chronic kidney disease
- risk factors
- prognostic factors
- respiratory syndrome coronavirus
- peritoneal dialysis
- gene expression
- cardiovascular events
- magnetic resonance imaging
- computed tomography
- genome wide
- contrast enhanced
- patient reported
- liver fibrosis